Explaining the Geographical Variation of HIV Among Injection Drug Users in the United States

References

• War and drugs: another powder trail. The Economist 2001; pp. 19–20
   Google Scholar
• Abdala N., Gleghorn A. A., Carney J. M., Heimer R. Can HIV-1-contaminated syringes be disinfected?: implications for transmission among injection drug users. J. Acquir Immune Defic. Syndr. 2001; 28(5)487–94
   PubMed Web of Science ®Google Scholar
• Bourgois P. Just another night in the shooting gallery. Theory, Culture, and Society 1998a; 15(2)37–66
   Web of Science ®Google Scholar
• Bourgois P. The moral economies of homeless heroin addicts: confronting ethnography, HIV risk, and everyday violence in san francisco shooting encampments [see comments]. Substance Use and Misuse 1998b; 33(11)2323–2351
   PubMed Web of Science ®Google Scholar
• Bourgois P. Anthropology and epidemiology on drugs: the challenges of cross-methodological and theoretical dialogue. International Journal of Drug Policy 2002; 13(4)259–269
   Google Scholar
• Bourgois P., Bruneau J. Needle exchange, HIV infection, and the politics of science: confronting Canada's cocaine injection epidemic with participant observation. Medical Anthropology 2000; 18(4)325–350
   Google Scholar
• Centers for Disease Control and Prevention. National HIV Serosurveillance Summary—Results Through 1992. U.S Department of Health and Human Services, Atlanta 1994
   Google Scholar
• Centers for Disease Control and Prevention. HIV Prevalence Trends in Selected Populations in the United States. Results from National Serosurveillance, 1993–1997. Centers for Disease Control and Prevention, Atlanta 2001; pp. 1–51
   Google Scholar
• Chaisson R. E., Bacchetti P., Osmond D., Brodie B., Sande M. A., Moss A. R. Cocaine use and HIV infection in intravenous drug users in san francisco [see comments]. Jama 1989; 261(4)561–565
   PubMed Web of Science ®Google Scholar
• Chaisson R. E., Moss A. R., Onishi R., Osmond D., Carlson J. R. Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco. Amer. J. Public Health 1987; 77(2)169–172
   PubMed Web of Science ®Google Scholar
• Ciccarone D., Bamberger J., Kral A., Edlin B., Hobart C., Moon A., Murphy E., Bourgois P., Harris H., Young D. Soft tissue infections among injection drug users–San Francisco, California, 1996–2000. MMWR Morb. Mortal. Wkly. Rep. 2001; 50(19)381–384
   PubMedGoogle Scholar
• Clatts M. C., Heimer R., Abdala N., Goldsamt L. A., Sotheran J. L., Anderson K. T., Gallo T. M., Hoffer L. D., Luciano P. A., Kyriakides T. HIV-1 transmission in injection paraphernalia: heating drug solutions may inactivate hiv-1. J. Acquir. Immune. Defic. Syndr. 1999; 22(2)194–199
   PubMed Web of Science ®Google Scholar
• Des Jarlais D. C., Friedman S. R., Novick D. M., et al. HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987. JAMA 1989; 261: 1008–1012
   PubMed Web of Science ®Google Scholar
• Des Jarlais D. C., Hagan H., Friedman S. R., Friedman P., Goldberg D., Frischer M., Green S., Tunving K., Ljungberg B., Wodak A., Ross M., Purchase D., Millson M. E., Myers T. Maintaining low HIV seroprevalence in populations of injecting drug users. JAMA, The Journal of the American Medical Association 1995; 274(15)1226
   PubMed Web of Science ®Google Scholar
• Des Jarlais D. C., Perlis T., Friedman S. R., Deren S., Chapman T., Sotheran J. L., Tortu S., Beardsley M., Paone D., Torian L. V., Beatrice S. T., Debernardo E., Monterroso E., Marmor M. Declining seroprevalence in a very large HIV epidemic: injecting drug users in New York City, 1991 to 1996. Amer. J. Public Health 1998; 88(12)1801
   PubMed Web of Science ®Google Scholar
• Drug Enforcement Agency. Domestic monitoring reports jan–dec for 1991–1993. U.S. Department of Justice, Washington, DC 1991–1993
   Google Scholar
• Drug Enforcement Agency. The mexican heroin trade. U.S. Department of Justice, Washington, DC 2000; pp. 13
   Google Scholar
• Flynn N., Jain S., Keddie E. M., Carlson J. R., Jennings M. B., Haverkos H. W., Nassar N., Anderson R., Conen S., Goldberg D. In vitro activity of readily available household materials against HIV-1- is bleach enough. J. Acquir. Immune. Defic. Syndr. 1994; 7(N7)747–753
   PubMedGoogle Scholar
• Friedman S. R., Jose B., Deren S., Des Jarlais D. C., Neaigus A. Risk factors for human immunodeficiency virus seroconversion among out-of-treatment drug injectors in high and low seroprevalence cities. The national aids research consortium. Amer. J. Epidemiol. 1995; 142(8)864–874
   PubMed Web of Science ®Google Scholar
• Friedman S. R., Perlis T., Des Jarlais D. C. Laws prohibiting over-the-counter syringe sales to injection drug users: relations to population density, HIV prevalence, and HIV incidence. Amer. J. Public Health 2001; 91(5)791–793
   PubMed Web of Science ®Google Scholar
• Gaughwin M. D., Gowans E., Ali R., Burrell C. Bloody needles—the volumes of blood transferred in simulations of needlestick injuries and shared use of syringes for injection of intravenous drugs. Aids 1991; 5(N8)1025–1027
   PubMedGoogle Scholar
• Hagan H., Thiede H., Weiss N. S., Hopkins S. G., Duchin J. S., Alexander E. R. Sharing of drug preparation equipment as a risk factor for hepatitis c. Amer. J. Public Health 2001; 91(1)42–46
   PubMed Web of Science ®Google Scholar
• Hahn R. A., Onorato I. M., Jones T. S., Dougherty J. Prevalence of HIV infection among intravenous drug users in the united states. Jama 1989; 261(18)2677–2684
   PubMed Web of Science ®Google Scholar
• Hast R. Review of the Drug Enforcement Administration's Heroin Signature and Domestic Monitor programs. United States General Accounting Office, Washington, DC 2001; pp. 8
   Google Scholar
• Holmberg S. D. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas [see comments]. Amer. J. Public Health 1996; 86(5)642–654
   PubMed Web of Science ®Google Scholar
• Koester S. K. Copping, running, and paraphernalia laws—contextual variables and needle risk behavior among injection drug users in Denver. Hum. Organ. 1994; 53(3)286–295
   Web of Science ®Google Scholar
• Kral A. H., Bluthenthal R. N., Booth R. E., Watters J. K. HIV seroprevalence among street-recruited injection drug and crack cocaine users in 16 US municipalities. Amer. J. Public Health 1998; 88(1)108–113
   PubMed Web of Science ®Google Scholar
• Kral A. H., Bluthenthal R. N., Lorvick J., Gee L., Bacchetti P., Edlin B. R. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet 2001; 357(9266)1397–1401
   PubMed Web of Science ®Google Scholar
• Lange W. R., Snyder F. R., Lozovsky D., Kaistha V., Kaczaniuk M. A., Jaffe J. H. Geographic distribution of human immunodeficiency virus markers in parenteral drug abusers. Amer. J. Public Health 1988; 78(4)443–446
   PubMed Web of Science ®Google Scholar
• Marmor M., Des Jarlais D. C., Cohen H., Friedman S. R., Beatrice S. T., Dubin N., El-Sadr W., Mildvan D., Yancovitz S., Mathur U. Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. Aids 1987; 1(1)39–44
   PubMed Web of Science ®Google Scholar
• Montoya I. D., Atkinson J. S. Determinants of HIV seroprevalence rates among sites participating in a community-based study of drug users. J. Acq. Immun. Defic. Synd. Hum. R 1996; 13(N2)169–176
   PubMedGoogle Scholar
• Moore L. D. Surveillance, addiction, and policy: the examples of South Africa and Afghanistan. Soz.-Praventivmed. 2002; 47: 001–002
   PubMedGoogle Scholar
• Rich J. D., Dickinson B. P., Carney J. M., Fisher A., Heimer R. Detection of HIV-1 nucleic acid and HIV-1 antibodies in needles and syringes used for non-intravenous injection. Aids 1998; 12(17)2345–2350
   PubMed Web of Science ®Google Scholar
• Singer M. Fighting drugs, fighting change: rethinking the war on drugs from a public health perspective. Medical Anthropology Quarterly, (In Press)
   Google Scholar
• Strang J., Keaney F., Butterworth G., Noble A., Best D. Different forms of heroin and their relationship to cook-up techniques: data on, and explanation of, use of lemon juice and other acids. Subst. Use Misuse 2001; 36(5)573–588
   PubMed Web of Science ®Google Scholar
• Watters J. K. Observations on the importance of social context in HIV transmission among intravenous drug users. In. J. Drug Issues 1989; 19: 9
   Web of Science ®Google Scholar